The Golden Helix Symposia

The Concept
The Golden Helix Symposia series are named after the house of Francis Crick (“The Golden Helix”; 19/20 Portugal Place, Cambridge, UK) to emphasize their focus on human genomics and personalized medicine. The topic of these symposia revolves around the fields of genomic and personalized medicine. In particular, these symposia series have the following features:

  • Symposia topics are selected by Golden Helix Institute’s International Advisory Council of distinguished research scientists from academia, government, and industry.
  • New and often ground- breaking science is presented at every meeting.
  • Symposia range in length from 2 to 3 days
  • Average attendance is 450 participants, coming from various countries worldwide.
  • Scientific excellence is ensured where important collaborations are formed, careers are enhanced, and new scientific breakthroughs are presented
  • Participants are staff scientists, post-doctoral fellows and students from academia, working in the field of personalized research, and scientists from pharmaceutical and biotechnology industries, government agencies and private and research foundations,
  • Conference venues are usually prestigious locations in major cities or summer retreats in Southern Mediterranean or Eastern regions

UPCOMING SYMPOSIUM: 3rd Global Genomic Medicine Collaborative Conference


3rd Global Genomic Medicine Collaborative Conference

Implementing Genomic Medicine into Practice

April 27-29, 2017, Athens, Greece


The 3rd Global Genomic Medicine Collaborative Conference will be organized in Athens, Greece, April 27-29, 2017.

The meeting will be organized by the Global Genomic Medicine Collaborative and the Golden Helix Foundation, as the local host. The 3rd Global Genomic Medicine Collaborative Conference is the first to be organized in Europe, following the successful events in the United States in 2014 and Singapore in 2015 and will focus on the implementation of Genomic Medicine into clinical practice.

Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.


The 3rd Global Genomic Medicine Collaborative Conference organizing Committee


Organized by:

Local Organizer:



Endorsed by:




About G2MC

The Global Genomic Medicine Collaborative



The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in Genomic Medicine Summit, the purpose of G2MC is to identify opportunities and foster global collaborations for enabling the demonstration of value and the effective use of genomics in medicine. Engaging multiple stakeholders across the globe, the G2MC group, under the auspices of the Roundtable on Genomics and Precision Health, seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally. To accomplish these goals, seven working groups were created, including communications, education, evidence, IT/bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.

Specifically, it is intended to:

  • Serve as nexus, clearinghouse, and knowledge base for genomic medicine activities globally;
  • Develop opportunities for global genomic medicine demonstration projects (implementation and outcomes research) and;
  • Capture and disseminate best practices for genomic medicine (in bioinformatics, education, evidence, pharmacogenomics, policy) across the global genomic medicine community.


Current Activities

The purpose and goals of the Global Genomic Medicine Collaborative (G2MC):

  • Develop projects with global participation
    • Opportunities to disseminate learnings for genomic medicine implementation
    • Educational platforms to support genomic medicine projects
    • Community engagement and access to global genomic medicine expertise
  • Creation of a registry or catalog of genomic medicine projects and programs across the globe to stimulate collaboration and efficiency in translation
  • Be a global policy forum for genomic medicine
    • Mapping the global genomic medicine landscape particularly as it relates to policy and implementation
  • Global eradication of preventable Stevens Johnson Syndrome/Toxic Epidermal Necrolysis


Previous Conferences 

2nd G2MC Conference; November 6-7, 2015, Singapore - Implementing Genomic Medicine into Practice

The meeting objectives were to:

  • Highlight nations or organizations around the world that are implementing genomic medicine into practice
  • Foster/facilitate collaborations to enable the implementation of genomic medicine
  • Highlight best practices and lessons learned to enable others to effectively implement genomic medicine approaches
  • Identify and develop solutions for overcoming obstacles to genomic medicine implementation
  • Identify and discuss regulations and policies that impact the implementation of genomic medicine
  • Create a global tool box for implementation of genomic medicine into practice


Attendee List

G2MC Group Photo


1st G2MC Conference; January 8-9, 2014, Washington DC, USA - Global Leaders in Genomic Medicine

The goals of the meeting were to:

  • Identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts.
  • Identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field.
  • Identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes.
  • Discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.



Venue of the 3rd Global Genomic Medicine Collaborative Conference

The 3rd Global Genomic Medicine Collaborative Conference will be held in the DIVANI Apollon Palace and Thalasso*****.

Divani Apollon Palace and Thalasso is a member of the Leading hotels of the world. This is a luxury beach resort in Athens situated in the exclusive area of Vouliagmeni, just 18km from the city centre. Guests enjoy, the pleasure of a private beach and an award winning Spa, the only one offering Thalassotherapy in the whole Attica region and one of the best Thalassotherapy centers in the Mediterranean.

Divani Apollon Palace and Spa is an excellent hotel for both leisure and business and offers quiet luxury at the prestigious Athenian Riviera.



Organizing Committee

Geoff Ginsburg (Duke University School of Medicine, Durham, NC, USA; Co-Chair)

Robyn Ward (University of Queensland, Queensland, Australia; Co-Chair)

George P. Patrinos (University of Patras, Patras, Greece; Local Chair)


Confirmed Speakers


To be announced soon

Scientific Program

Scientific Program


Please note: Agenda and speakers are subject to change.


DAY 1: April 27, 2016



10:00–13:00  Registration


13:00–13:30 Welcoming Remarks/Keynote #1 - Victor Dzau


National Academy of Medicine


Session I: Large-Scale National Sequencing Programs: Impact on Clinical Medicine

Moderator: Alan Shuldiner, Vice President and Co-Head, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA


13:30 Genome Qatar

Said Ismail

Programme Manager

Genome Qatar, Qatar



Fahd Al-Mulla

Director of Genomic Medicine Center and Professor of Molecular Pathology

Kuwait University, Saudi Arabia


13:50 United States: PMI and Million Veterans Program

Teri Manolio

Director, Division of Genomic Medicine

National Human Genome Research Institute, USA


14:00 China’s Precision Medicine Initiative

Yixue Li


Shanghai Institutes for Biological Sciences, China


14:10 Genome England

Clare Turnbull

Senior Researcher

The Institute of Cancer Research, United Kingdom


14:20 Australian Genomics Health Alliance

Kathryn North


Murdoch Childrens Research Institute


14:30  Genomics Israel

Gad Rennert


Clalit National Israeli Cancer Control Center, Israel


14:40 TBD


14:50 South America

Gabriella Repetto

Director, Center for Genetics and Genomics

Universidad del Desarrollo, Chile


15:00 H3Africa

Raj Ramesar

Head, Division of Human Genetics

University of Cape Town, South Africa


15:10 Genomics in Mexico

Gerardo Jimenez-Sanchez

Executive President

Genómica Médica & GBC Group - ‎Genómica Médica, Mexico


15:20 Discussion with Speakers and Attendees



15:30–16:00 COFFEE BREAK



Session II: Progress in Diagnosing Rare Diseases – International Opportunities

Moderator: Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute (USA)


16:00  RD-Connect/RD-Neuromics

Olaf Riess

ESHG Chief

Tübingen Newcastle, Germany


16:15 Undiagnosed Severe Intellectual Disability

Han Brunner

Head, Clinical Genetics

Maastricht UMC, Netherlands


16:30  Undiagnosed Diseases Network International

Domenica Taruscio


Istituto Superiore di Sanita (ISS), Italy


16:45 GUaRDIAN Consortium on Rare Genetic Diseases in India

Vinod Scaria

Institute of Genomics and Integrative Biology, India


17:00 Initiative on Rare and Undiagnosed Diseases (IRUD)

Kenjiro Kosaki

Associate Professor, Division of Medical Genetics

Keio University School of Medicine, Japan


17:15  CARE4RARE

Kym Boycott

Investigator, Clinical Geneticist

CHEO Research Institute, Canada


17:30  University of Alabama’s Undiagnosed Diseases Program

Bruce Korf

Wayne H. and Sara Crews Finley Chair in Medical Genetics

Professor and Chair, Department of Genetics

University of Alabama, Birmingham


17:45  Discussion with Speakers and Attendees




DAY 2: April 28, 2016


08:00–08:30 Keynote #2 -  Stylianos Antonarakis

Professor and Chairman of Genetic Medicine

University of Geneva Medical School


Session III: Pharmacogenomics in the Clinic: International Progress          

Moderator: George Patrinos, Assistant Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras


08:30  Rare Drug Outcomes

Federico Innocenti

Research Associate Professor, Medicine-Hematology

University of North Carolina Chapel Hill, USA


08:40 UPGx

Henk-Jan Guchelaar

Chair, Department of Clinical Pharmacy

 Leiden University Medical Center, Netherlands



Dan Roden

Professor of Medicine

Vanderbilt University School of Medicine, USA


09:00 CPIC

Mary Relling

Chair, Pharmaceutical Sciences Department

St. Jude Children’s Research Hospital, USA


09:10 Public Health Pharmacogenomics

George P. Patrinos

Assistant Professor of Pharmacogenomics and Pharmaceutical Biotechnology

University of Patras, Greece


09:20  NGS in PGx

Magnus Ingelman-Sundberg


Karolinska Institutet, Sweden


09:30  European Society of Pharmacogenomics

Ron van Schaik

Full Professor, Pharmacogenetics

Erasmus Medical Center, Netherlands


09:40  CHMP Pharmacogenomics Working Party/European Medicines Agency

Markus Paulmichl


Paracelsus Medical University, Austria


9:50  SEAPharm

Wasun Chantratita

Associate Professor, Department of Pathology

Ramathibidi Hospital, Thailand


10:00 TBD


10:10  TBD


10:20 Discussion with Speakers and Attendees


10:30–11:00  COFFEE BREAK


Session IV: Cancer Genomic Medicine – Targeted Therapies and Outcomes

Moderator: TBD


11:00 TBD

Ken Offitt

Chief, Clinical Genetics Service

Memorial Sloan Kettering Cancer Center, USA


11:15  TBD

Judy Garber

Director, Cancer Risk and Prevention Clinic

Brigham and Women’s Hospital, USA


11:30 TBD

Sharon Plon

Professor, Pediatrics-Oncology

Baylor College of Medicine, USA


11:45 TBD

Patrick Tan

Professor, Cancer & Stem Cell Biology Programme

DukeNUS Medical School, Singapore


12:00  TBD


12:15  TBD


12:30 TBD


12:45 Discussion with Speakers and Attendees



13:00–14:00 LUNCH BREAK



Session V: Policy and Workforce Generation

Moderator: Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia, and Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham


14:00 TBD

Sue Hill

Chief Scientific Officer

NHS England, United Kingdom


14:20  TBD

Robyn Ward

Deputy Vice-Chancellor of Research, and Vice President of Research

The University of Queensland, Australia


14:40 TBD

Catalina Lopez-Correa

Chief Scientific Officer and Vice President, Sectors

Genome British Columbia, Canada


15:00   TBD

Petra Laux

Head, Global and Public Affairs

Novartis International AG


15:20 TBD

Warwick Anderson

Secretary General

Human Frontier Science Program, France


15:40  Discussion with Speakers and Attendees



16:00–16:30  BREAK



16:30–17:30  Breakout Sessions


18:00 Depart for Dinner

Acropolis Museum


20:30   Dinner

Acropolis Museum


DAY 3: April 29, 2016


08:00–09:30 Breakout Reports and Discussion


09:30–10:00  COFFEE BREAK


Session VI: Data Science (with GA4GH)

Moderators: Steve Bleyl, Medical Director, Clinical Genetics Institute at Intermountain Healthcare, and Grant Wood, Senior IT Strategist, Clinical Genetics Institute at Intermountain Healthcare


10:00  TBD

Peter Goodhand

Executive Director

Global Alliance for Genomics and Health (GA4GH)


10:15 TBD

Augusto Rendon

Director of Bioinformatics at Genomics England

Cambridge University, United Kingdom


10:30  TBD


10:45  TBD


11:00  TBD


11:15 TBD


11:30 Discussion with Speakers and Attendees


12:00–12:30 Closing Remarks


12:30 Meeting Adjourns


12:30–14:00  G2MC Steering Committee Meeting (by invitation only)





To be announced soon 



Click here to register and submit an abstract.

Click here to register withou submitting an abstract.

Connect With Us

Subscribe to all RSS or just the section
you care..


Looking for Golden Helix, Inc

Our Videos

Genetic Analysis in Translational medicine:

You are here: Home Education Golden Helix Conferences The Golden Helix Symposia Upcoming Symposium